Manasi K. Mayekar

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance”.

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

Nature Genetics(2023)10.1038/s41588-023-01592-8

N/A

1.9DataRank · unranked

88 citations

Philippe Gui, Manasi K. Mayekar, Emily K. Law, Oriol Pich, Chris Bailey +80 more

Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistance

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.18.423280

N/A

0DataRank · unranked

19 citations

Deborah R. Caswell, Natalie I. Vokes, Emily K. Law, Wei Wu, William Hill +43 more

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR mutant lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.26.356352

N/A

0DataRank · unranked

1 citations

Wei Wu, Niki Karachaliou, Collin M. Blakely, Junji Suzuki, Siraj M. Ali +14 more

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer

Journal of Clinical Investigation(2022)10.1172/jci145099

N/A

0DataRank · unranked

57 citations

Wei Wu, Niki Karachaliou, Collin M. Blakely, Junji Suzuki, Yu‐Ting Chou +23 more